Cargando…

Paradoxical improvement of life quality in the COVID-19 era in psoriasis patients

BACKGROUND: Psoriasis is a chronic immune-mediated inflammatory disease. Beyond the physical dimensions, the disease has an extensive emotional and psychosocial effect on patients, influencing their quality of life, social life and interpersonal relationships. Thus patient-reported outcomes are a cr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boch, Katharina, Zillikens, Detlef, Ludwig, Ralf J., Thaçi, Diamant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514635/ https://www.ncbi.nlm.nih.gov/pubmed/36166453 http://dx.doi.org/10.1371/journal.pone.0275293

Ejemplares similares

Case report: Optical coherence tomography for monitoring biologic therapy in psoriasis and atopic dermatitis
por: Ha-Wissel, Linh, et al.
Publicado: (2022)

Secukinumab-induced chronic discoid lupus erythematosus
por: Chatzimichail, Giannis, et al.
Publicado: (2020)

Dupilumab in Inflammatory Skin Diseases: A Systematic Review
por: Olbrich, Henning, et al.
Publicado: (2023)

Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series
por: Ständer, Sascha, et al.
Publicado: (2020)

Case report: Clinical features of COVID-19 vaccine-induced exacerbation of psoriasis–A case series and mini review
por: Ständer, Sascha, et al.
Publicado: (2022)

Evaluation of clinical and laboratory characteristics of patients with cutaneous sarcoidosis: A single-center retrospective cohort study
por: Boch, Katharina, et al.
Publicado: (2022)

Treatment Options and Goals for Patients with Generalized Pustular Psoriasis
por: Krueger, James, et al.
Publicado: (2022)

Sustained CD19(+)CD27(+) Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022)

Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study
por: Olbrich, Henning, et al.
Publicado: (2023)

Lichen Planus
por: Boch, Katharina, et al.
Publicado: (2021)

Spotlight on Topical Long-Term Management of Plaque Psoriasis
por: Carrascosa, Jose Manuel, et al.
Publicado: (2020)

Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid
por: Khil'chenko, Stanislav, et al.
Publicado: (2020)

The impact of the Covid-19 pandemic on quality of life in skin cancer patients
por: Kurzhals, Jonas K., et al.
Publicado: (2021)

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022)

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020)

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
por: Wasel, Norman, et al.
Publicado: (2020)

Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
por: Thaçi, Diamant, et al.
Publicado: (2022)

Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice
por: Boch, Katharina, et al.
Publicado: (2021)

The paradox of re-opening schools in Zimbabwe in the COVID-19 era
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2020)

Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases
por: Mössner, Rotraut, et al.
Publicado: (2008)

Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis
por: Augustin, Matthias, et al.
Publicado: (2023)

Efficacy of Tildrakizumab Across Different Body Weights in Moderate-to-Severe Psoriasis Over 5 Years: Pooled Analyses from the reSURFACE Pivotal Studies
por: Thaçi, Diamant, et al.
Publicado: (2022)

General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach
por: Thaçi, Diamant, et al.
Publicado: (2020)

Should biologics for psoriasis be interrupted in the era of COVID-19?
por: Lebwohl, Mark, et al.
Publicado: (2020)

Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials
por: REICH, Kristian, et al.
Publicado: (2022)

Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon
por: Vlachakis, Panayotis K., et al.
Publicado: (2020)

Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies
por: Kavanaugh, Arthur, et al.
Publicado: (2019)

Quality of life in patients with psoriasis
por: Bhosle, Monali J, et al.
Publicado: (2006)

Quality of life in patients with psoriasis
por: Bouhamed, M., et al.
Publicado: (2021)

Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
por: Nicolescu, Alin Codrut, et al.
Publicado: (2022)

Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral Center
por: Kurzhals, Jonas K., et al.
Publicado: (2021)

Paradoxical Flare of Psoriasis after Ustekinumab Therapy
por: Lee, Ho Yeol, et al.
Publicado: (2017)

Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?
por: Lu, Jiawei, et al.
Publicado: (2023)

Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care
por: da Silva, Neuza, et al.
Publicado: (2020)

Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
por: Ujiie, Hideyuki, et al.
Publicado: (2022)

Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis
por: Iskandar, I.Y.K., et al.
Publicado: (2017)

Lichen sclerosus: The 2023 update
por: De Luca, David A., et al.
Publicado: (2023)

Stigmatization and Quality of Life in Patients with Psoriasis
por: Jankowiak, Barbara, et al.
Publicado: (2020)

Impact of Psoriasis on Quality of Life
por: Agarwal, Komal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lb8ai61fi08ka9qpgabauq6sql